Other
Methadone
0
Pipeline Programs↗
7
Active Trials↗
4
Companies Involved↗
Methadone is an early-stage landscape with 0 programs across 4 companies. The most active players are Relmada Therapeutics, Inc., Merck & Co., Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
50
clinical trials
Completed33 · 66%
Recruiting4 · 8%
Unknown status4 · 8%
Terminated3 · 6%
Active, not recruiting2 · 4%
Withdrawn2 · 4%
Other2 · 4%
Clinical Trials
Trial Activity
50 trials
Methadone-Maintained Smokers Switching to E-Cigarettes
Active, not recruiting·—·Phase 4·NCT05206435·240 enrolled
PO Methadone Ortho Outpatient
Not yet recruiting·—·Phase 3·NCT06351215·100 enrolled
Methadone Effects on Zidovudine (ZDV, AZT) Disposition
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00000800·15 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)